In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Auxilium Pharmaceuticals nets $43.3mm with private financing

Executive Summary

Auxilium Pharmaceuticals (developing therapeutics to for sexual health and urological conditions) has netted $43.3mm with the private placement of 5.5mm common shares priced at $8.50 each (a 9% discount). Selected institutional investors, including Atlas Ventures, Visium Capital Management, Balyasny Asset Management, and a private backer participated. Thomas Weisel Partners and Roth Capital Partners acted as placement agents for the transaction.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies